This is a routine annual meeting with no signs of shareholder activism or governance disputes. The recent board appointment of John Gallina, a former CFO of Elevance Health, suggests a focus on financial and audit expertise. Traders should monitor for any future filings indicating activist involvement or governance challenges, but this proxy indicates stable management control.
Price Chart
Executive Summary
CVS Health is holding its 2026 annual shareholder meeting to vote on director elections, auditor ratification, executive compensation, and a shareholder proposal to lower the threshold for shareholder action by written consent. This filing follows the recent addition of John Gallina to the board, indicating continuity in governance.
Key Facts
- Annual meeting scheduled for May 14, 2026, to vote on 13 director nominees, auditor ratification, executive compensation (Say on Pay), and a new incentive plan.
- Shareholders are asked to vote against a proposal to reduce the threshold for shareholder action by written consent.
- Recent 8-K filing confirms John Gallina's election to the board on March 19, 2026, as an independent director and member of the Audit Committee.
- The filing is a standard annual proxy statement with no major governance changes or contentious issues.
Financial Impact
No direct financial impact from this filing. The vote on executive compensation and incentive plans relates to ongoing corporate governance.
Risk Factors
- Potential for future shareholder activism if governance or performance issues arise.
- Regulatory or compliance risks related to executive compensation disclosures.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001308179-26-000202 |
| Document: 0001308179-26-000202-index-headers.html | 0001308179-26-000202 |
| Document: 0001308179-26-000202-index.html | 0001308179-26-000202 |
| Document: 0001308179-26-000202.txt | 0001308179-26-000202 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $99.12 $97.23 | ▼ −1.91% | ▼ −1.31% | $85.20 (−14.04%) |
Jul 10, 2026 11w ago | Press Release | $104.15 $95.46 | ▼ −8.35% | ▼ −10.77% | $85.20 (−18.19%) |
Jun 29, 2026 13w ago | Court Ruling | $103.58 $107.74 | ▲ +4.02% | ▲ +4.30% | $85.20 (−17.74%) |
May 22, 2026 18w ago | S-3ASR | $90.55 $101.57 | ▲ +12.17% | ▲ +14.44% | $85.20 (−5.91%) |
May 19, 2026 19w ago | Court Ruling | $93.11 $99.16 | ▲ +6.50% | ▲ +6.54% | $85.20 (−8.49%) |
May 15, 2026 20w ago | Court Ruling | $95.88 $100.68 | ▲ +5.01% | ▲ +2.89% | $85.20 (−11.14%) |
May 6, 2026 21w ago | 8-K | $86.76 $91.37 | ▲ +5.32% | ▲ +2.54% | $85.20 (−1.79%) |
May 4, 2026 21w ago | Court Ruling | $82.01 $89.50 | ▲ +9.13% | ▲ +3.34% | $85.20 (+3.89%) |
Apr 29, 2026 22w ago | Court Ruling | $83.84 $92.97 | ▲ +10.89% | ▲ +4.85% | $85.20 (+1.62%) |
Apr 14, 2026 24w ago | Court Ruling | $77.60 $92.22 | ▼ −18.85% | ▼ −12.55% | $85.20 (−9.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access